RecruitingPhase 3NCT05456503
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
Studying Frontotemporal dementia, right temporal atrophy variant
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Pennsylvania
- Principal Investigator
- Jeffrey S PhillipsUniversity of Pennsylvania
- Intervention
- [18F]-PI-2620(drug)
- Enrollment
- 72 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2028
Study locations (1)
- Perelman Center for Advance Medicine, Philadelphia, Pennsylvania, United States
Collaborators
National Institutes of Health (NIH)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05456503 on ClinicalTrials.govOther trials for Frontotemporal dementia, right temporal atrophy variant
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07316413Repetitive Transcranial Magnetic Stimulation in Frontotemporal Lobar DegenerationUniversità degli Studi di Brescia
- RECRUITINGNANCT06490822The Skin as a Window to the Central Nervous System in Frontotempolar Lombar DegenerationNantes University Hospital
See all trials for Frontotemporal dementia, right temporal atrophy variant →